{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:00:56Z","timestamp":1787652056731,"version":"build-2736575974"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n \n Achieving and maintaining a serum 25-hydroxyvitamin D (25[OH]D) level of 40 ng\/mL or higher, compared with 20 to 30 ng\/mL, may lower diabetes risk among adults with prediabetes. It is not known whether a genetically defined subgroup is more likely to experience benefits from targeting higher 25(OH)D levels with vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n supplementation.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n To assess the role of common polymorphisms of the vitamin D receptor (VDR) in the association between supplementation with 4000 IU\/d of vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n and the risk of diabetes among adults with prediabetes.\n <\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This genetic association study conducted a VDR genotype analysis of 3 common polymorphisms\u2014ApaI, BsmI, and FokI\u2014among 2098 participants in the Vitamin D and Type 2 Diabetes (D2d) clinical trial with available intratrial 25(OH)D levels and genotyping. The D2d trial was conducted from October 1, 2013, to November 28, 2018, with statistical analysis performed from January 3 to November 30, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n \n Receipt of 4000 IU\/d of vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n vs placebo for a median of 2.5 years (IQR, 1.8-3.5 years).\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n In the discovery phase analysis among 1903 participants with available data, the risk of diabetes across different intratrial mean 25(OH)D levels in association with the VDR polymorphisms was examined. This was followed by a test phase analysis examining the response to vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n supplementation on incident diabetes among 2098 participants according to the ApaI genotypes.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 2098 adults with prediabetes (mean [SD] age, 60.2 [9.9] years; 1169 men [55.7%]) in the test phase analysis, 618 with ApaI AA alleles exhibited no response to treatment with vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n (hazard ratio [HR], 1.02 [95% CI, 0.72-1.44]; models adjusted for study site, race and ethnicity, sex, baseline age, body mass index, usual physical activity, statin use, and intratrial weight change). In contrast, 1480 participants with ApaI AC and CC genotypes showed a 19% decrease in the risk of diabetes with vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n (HR, 0.81 [95% CI, 0.66-0.99]).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n \n This genetic association study of adults with prediabetes suggests that diabetes risk reduction after supplementation with 4000 IU\/d of vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n was restricted to participants carrying the AC and CC alleles of the ApaI polymorphism. These findings support the potential role of ApaI genotyping in identifying individuals most likely to experience benefits from high-dose vitamin D\n \n 3<\/jats:sub>\n <\/jats:bold>\n treatment to reduce diabetes risk.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.7332","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:30:31Z","timestamp":1776958231000},"page":"e267332","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes"],"prefix":"10.1001","volume":"9","author":[{"given":"Bess","family":"Dawson-Hughes","sequence":"first","affiliation":[{"name":"Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon S.","family":"Huggins","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Vickery","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Powers","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastassios G.","family":"Pittas","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"3","key":"zoi260238r1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7326\/M22-3018","article-title":"Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials.","volume":"176","author":"Pittas","year":"2023","journal-title":"Ann Intern Med"},{"key":"zoi260238r2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900906","article-title":"Vitamin D supplementation and prevention of type 2 diabetes.","author":"Pittas","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi260238r3","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2337\/dc20-1765","article-title":"Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 Diabetes (D2d) study.","volume":"43","author":"Dawson-Hughes","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi260238r4","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0006","article-title":"Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 Diabetes (D2d) study. Diabetes Care 2020;43:2916-2922.","volume":"44","author":"Dawson-Hughes","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"zoi260238r5","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1210\/clinem\/dgae221","article-title":"Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: a prospective cohort study.","volume":"109","author":"Fu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"zoi260238r6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00125-005-1802-7","article-title":"Vitamin D and diabetes.","volume":"48","author":"Mathieu","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"zoi260238r7","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.74255","article-title":"Vitamin D increases glucose stimulated insulin secretion from insulin producing beta cells (INS1E).","volume":"17","author":"Bornstedt","year":"2019","journal-title":"Int J Endocrinol Metab"},{"issue":"12","key":"zoi260238r8","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.2337\/dc14-1005","article-title":"Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial.","volume":"37","author":"Pittas","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"zoi260238r9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jclinepi.2008.12.004","article-title":"Strengthening the Reporting of Genetic Association studies (STREGA): an extension of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.","volume":"62","author":"Little","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"zoi260238r10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20142010.","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"zoi260238r11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2013.08.012","article-title":"An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program.","volume":"426","author":"Bedner","year":"2013","journal-title":"Clin Chim Acta"},{"key":"zoi260238r12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsbmb.2017.07.018","article-title":"Hydroxyvitamin D assays: an historical perspective from DEQAS.","volume":"177","author":"Carter","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"zoi260238r13","doi-asserted-by":"publisher","journal-title":"J Clin Endocrinol Metab","DOI":"10.1210\/clinem\/dgae314"},{"key":"zoi260238r15","doi-asserted-by":"publisher","journal-title":"PLoS One","DOI":"10.1371\/journal.pone.0155004"},{"issue":"9736","key":"zoi260238r16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0140-6736(10)60588-0","article-title":"Common genetic determinants of vitamin D insufficiency: a genome-wide association study.","volume":"376","author":"Wang","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"zoi260238r17","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/hmg\/ddq155","article-title":"Genome-wide association study of circulating vitamin D levels.","volume":"19","author":"Ahn","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"7","key":"zoi260238r18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes.","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"issue":"9","key":"zoi260238r19","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2337\/dc19-0244","article-title":"Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).","volume":"42","author":"Perreault","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi260238r20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.116.025483","article-title":"Effect of long-term metformin and lifestyle in the Diabetes Prevention Program and its outcome study on coronary artery calcium.","volume":"136","author":"Goldberg","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"zoi260238r21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260238r22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajcnut.2023.03.021","article-title":"Effect of intratrial mean 25(OH)D concentration on diabetes risk, by race and weight: an ancillary analysis in the D2d study.","volume":"118","author":"Chatterjee","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"zoi260238r14"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848109\/dawsonhughes_2026_oi_260238_1776356630.62195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:30:32Z","timestamp":1776958232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.7332","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}